If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi™ (glucagon) nasal powder
3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
BAQSIMI™ (glucagon) nasal powder: Description
Baqsimi (glucagon nasal powder) is a glucagon dry nasal powder delivered via a ready-to-use nasal dosing device.
Baqsimi is a 3 mg glucagon dry nasal powder. It is delivered via a nasal dosing device that
is ready-to-use and requires no reconstitution
is a compact, portable, single-use, drug-device combination, and
Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1
Enclosed Prescribing Information
BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly
1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
2. Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: July 24, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 8pm ET
